NL · NLI Holdings Inc. Common Stock
View on chartInsiders & Stakes
| Cecil H. Moore Jr. Director | ▲ Buy | Grant | 49,550 Shares held | 5/14/2026 | View profile |
| Loretta J. Feehan Director | ▲ Buy | Grant | 41,050 Shares held | 5/14/2026 | View profile |
| John E. Harper Director | ▲ Buy | Grant | 38,050 Shares held | 5/14/2026 | View profile |
| Meredith W. Mendes Director | ▲ Buy | Grant | 34,550 Shares held | 5/14/2026 | View profile |
| Kevin B. Kramer Director | ▲ Buy | Grant | 24,350 Shares held | 5/14/2026 | View profile |
| Thomas P. Stafford Director | ▲ Buy | Grant | 23,200 Shares held | 5/18/2023 | View profile |
| R. Gerald Dr Turner Director | ▲ Buy | Grant | 9,739 Shares held | 5/14/2026 | View profile |
| Randall Colin Gouveia SVP, GM of EMS | ▲ Buy | Grant | 2,500 Shares held | 5/19/2022 | View profile |
| Amy A. Samford Executive VP and CFO | ▲ Buy | Open Market | 2,000 Shares held | 12/6/2022 | View profile |
| Bryan A. Hanley Senior VP and Treasurer | ▲ Buy | Open Market | 1,250 Shares held | 3/11/2025 | View profile |
| CONTRAN CORP 10% Owner | ▼ Sell | Open Market | 0 Shares held | 6/1/2022 | View profile |
Transaction History
| R. Gerald Dr Turner | ▲ Buy | Grant | 6,000 | $40K | 5/14/2026 |
| Cecil H. Moore Jr. | ▲ Buy | Grant | 6,000 | $40K | 5/14/2026 |
| Meredith W. Mendes | ▲ Buy | Grant | 6,000 | $40K | 5/14/2026 |
| Kevin B. Kramer | ▲ Buy | Grant | 6,000 | $40K | 5/14/2026 |
| John E. Harper | ▲ Buy | Grant | 6,000 | $40K | 5/14/2026 |
| Loretta J. Feehan | ▲ Buy | Grant | 6,000 | $40K | 5/14/2026 |
| Kevin B. Kramer | ▲ Buy | Grant | 2,500 | $20K | 5/15/2025 |
| Meredith W. Mendes | ▲ Buy | Grant | 2,500 | $20K | 5/15/2025 |
| John E. Harper | ▲ Buy | Grant | 2,500 | $20K | 5/15/2025 |
| R. Gerald Dr Turner | ▲ Buy | Grant | 2,500 | $20K | 5/15/2025 |
| Cecil H. Moore Jr. | ▲ Buy | Grant | 2,500 | $20K | 5/15/2025 |
| Loretta J. Feehan | ▲ Buy | Grant | 2,500 | $20K | 5/15/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 500 | $4K | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 470 | $3K | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 1,000 | $7K | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 100 | $718 | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 1,000 | $7K | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 9 | $65 | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 1,000 | $7K | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 1,000 | $7K | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 122 | $881 | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 113 | $817 | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 186 | $1K | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 188 | $1K | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 100 | $734 | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 588 | $4K | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 1 | $7 | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 10 | $74 | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 113 | $843 | 3/12/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 1,080 | $7K | 3/11/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 420 | $3K | 3/11/2025 |
| Bryan A. Hanley | ▲ Buy | Open Market | 250 | $2K | 3/11/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 1,000 | $6K | 3/11/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 1,000 | $6K | 3/11/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 1,000 | $6K | 3/11/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 500 | $3K | 3/11/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 1,000 | $7K | 3/11/2025 |
| Kevin B. Kramer | ▲ Buy | Open Market | 500 | $3K | 3/11/2025 |
| Cecil H. Moore Jr. | ▲ Buy | Grant | 2,850 | — | 5/16/2024 |
| Meredith W. Mendes | ▲ Buy | Grant | 2,850 | — | 5/16/2024 |
| Kevin B. Kramer | ▲ Buy | Grant | 2,850 | — | 5/16/2024 |
| John E. Harper | ▲ Buy | Grant | 2,850 | — | 5/16/2024 |
| Loretta J. Feehan | ▲ Buy | Grant | 2,850 | — | 5/16/2024 |
| Thomas P. Stafford | ▲ Buy | Grant | 3,550 | — | 5/18/2023 |
| Cecil H. Moore Jr. | ▲ Buy | Grant | 3,550 | — | 5/18/2023 |
| Meredith W. Mendes | ▲ Buy | Grant | 3,550 | — | 5/18/2023 |
| John E. Harper | ▲ Buy | Grant | 3,550 | — | 5/18/2023 |
| Loretta J. Feehan | ▲ Buy | Grant | 3,550 | — | 5/18/2023 |
| Amy A. Samford | ▲ Buy | Open Market | 2,000 | $14K | 12/6/2022 |
| CONTRAN CORP | ▼ Sell | Open Market | 2,000 | $16K | 6/1/2022 |
| Thomas P. Stafford | ▲ Buy | Grant | 2,500 | — | 5/19/2022 |
| Cecil H. Moore Jr. | ▲ Buy | Grant | 2,500 | — | 5/19/2022 |
| Meredith W. Mendes | ▲ Buy | Grant | 2,500 | — | 5/19/2022 |
| John E. Harper | ▲ Buy | Grant | 2,500 | — | 5/19/2022 |
| Randall Colin Gouveia | ▲ Buy | Grant | 2,500 | — | 5/19/2022 |
| Loretta J. Feehan | ▲ Buy | Grant | 2,500 | — | 5/19/2022 |
| Thomas P. Stafford | ▲ Buy | Grant | 2,750 | — | 5/20/2021 |
| Meredith W. Mendes | ▲ Buy | Grant | 2,750 | — | 5/20/2021 |
| Loretta J. Feehan | ▲ Buy | Grant | 2,750 | — | 5/20/2021 |
| Cecil H. Moore Jr. | ▲ Buy | Grant | 2,750 | — | 5/20/2021 |
| John E. Harper | ▲ Buy | Grant | 2,750 | — | 5/20/2021 |
| Meredith W. Mendes | ▲ Buy | Grant | 6,650 | — | 5/21/2020 |
| Loretta J. Feehan | ▲ Buy | Grant | 6,650 | — | 5/21/2020 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
NL Upgraded to Outperform on CompX Strength, Kronos Recovery
The rating upgrade reflects a more positive outlook after CompX's strong performance and Kronos's recovery. NL is near its 52‑week low but sits above the $5.65 support level, and the RSI of 59.5 indicates a moderate trend.
NL Upgraded to Outperform on CompX Strength, Kronos Recovery. The rating upgrade reflects a more positive outlook after CompX's strong performance and Kronos's recovery. NL is near its 52‑week low but sits above the $5.65 support level, and the RSI of 59.5 indicates a moderate trend.